EDGAR Filing Documents for 0001558370-23-003731

Form 8-K - Current report:

SEC Accession No. 0001558370-23-003731

Filing Date

2023-03-14

Accepted

2023-03-14 16:45:13

Documents

Period of Report

2023-03-08

Items

Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	edit-20230308x8k.htm iXBRL	8-K	43162
2	EX-3.1	edit-20230308xex3d1.htm	EX-3.1	187806
	Complete submission text file	0001558370-23-003731.txt		379845

Data Files

Seq	Description	Document	Type	Size
3	EX-101.SCH	edit-20230308.xsd	EX-101.SCH	3150
4	EX-101.LAB	edit-20230308_lab.xml	EX-101.LAB	15893
5	EX-101.PRE	edit-20230308_pre.xml	EX-101.PRE	10296
7	EXTRACTED XBRL INSTANCE DOCUMENT	edit-20230308x8k_htm.xml	XML	4812

Mailing Address 11 HURLEY ST. CAMBRIDGE MA 02141

Business Address 11 HURLEY ST. CAMBRIDGE MA 02141 617-401-9000

Editas Medicine, Inc. (Filer) CIK: 0001650664 (see all company filings)